Itraconazole resistance in Aspergillus fumigatus

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1364-1368

  Denning, David W ^a,b   Venkateswarlu, K ^c   Oakley, Karen L ^b,d   Anderson, M J ^b   Manning, N J ^e   Stevens, David A ^f   Warnock, David W ^g   Kelly, Steven L ^c  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d HOPE HOSPITAL   (United Kingdom)

^e SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^f SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^g NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ERGOSTEROL; ITRACONAZOLE; MEVALONIC ACID;

ADULT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CASE REPORT; DEMETHYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR RECOGNITION; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0030990657     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1364     Document Type: Article

References (31)

1. Anderson, M. J., K. Gull, and D. W. Denning. 1996. Molecular typing by random amplification of polymorphic DNA and M13 Southern hybridization of related paired isolates of Aspergillus fumigatus. J. Clin. Microbiol. 34:87-93.
2. Ballard, S. A., S. W. Ellis, S. L. Kelly, and P. F. Troke. 1990. Ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents. J. Med. Vet. Mycol. 28:335-343.
3. Barnes, A. J., and D. W. Denning. 1993. Aspergilli - significance as pathogens. Rev. Med. Microbiol. 4:176-180.
4. Ben-Yaacov, R., S. Knoller, G. A. Caldwell, J. M. Becker, and Y. Koltin. 1994. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob. Agents Chemother. 38:648-652.
5. Bodey, G., B. Bueltmann, W. Duguid, D. Gibbs, H. Hanak, M. Hotchi, G. Mall, P. Martino, F. Meunier, S. Milliken, S. Naoe, M. Okudaira, D. Scevola, and J. van't Wout. 1992. Fungal infections in cancer patients: an international autopsy survey. Eur. J. Clin. Microbiol. Infect. Dis. 11:99-109.
6. Carlson, G. L., M. Birch, M. M. Mughal, and D. W. Denning. 1996. Aspergillus wound infection following laparostomy. J. Infect. 33:119-122.
7. Denning, D. W., K. V. Clemons, L. H. Hanson, and D. A. Stevens. 1990. Restriction endonuclease analysis of total cellular DNA of Aspergillus fumigatus isolates of geographically and epidemiologically diverse origin. J. Infect. Dis. 162:1151-1158.
8. Denning, D. W., S. Follansbee, M. Scolaro, S. Norris, D. Edelstein, and D. A. Stevens. 1991. Pulmonary aspergillosis in AIDS. N. Engl. J. Med. 324:654-662.
9. Denning, D. W., L. Hall, M. Jackson, and S. Hollis. 1995. Activity of D0870 in two murine models of invasive aspergillosis. Antimicrob. Agents Chemother. 39:1809-1814.
10. Denning, D. W., L. H. Hanson, A. M. Perlman, and D. A. Stevens. 1992. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn. Microbiol. Infect. Dis. 15:21-34.
11. Denning, D. W., L. H. Hanson, and D. A. Stevens. 1990. In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus species. Eur. J. Clin. Microbiol. Infect. Dis. 9:693-697.
12. Denning, D. W., R. M. Tucker, L. H. Hanson, and D. A. Stevens. 1989. Treatment of invasive aspergillosis with itraconazole. Am. J. Med. 86:791-800.
13. de Waard, M. A., and J. G. M. van Nistelrooy. 1980. An energy-dependent efflux mechanism for fenarimol in a wild-type strain and fenarimol-resistant mutants of Aspergillus nidulans. Pestic. Biochem. Physiol. 13:255-266.
14. Groll, A., P. M. Shah, C. Menzel, G. Just, M. Schneider, and K. Hübner. 1994. Invasive mycosis in post-mortem findings. J. Infect. 28:57. (Abstract.)
15. Hitchcock, C. A., G. W. Pye, P. F. Troke, E. M. Johnson, and D. W. Warnock. 1993. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37:1962-1965.
16. Hostetler, J. S., L. H. Hanson, and D. A. Stevens. 1992. Effect of cyclodextrin on the pharmacology of antifungal azoles. Antimicrob. Agents Chemother. 36:477-480.
17. Joseph-Horne, T., D. Holloman, R. S. T. Loeffler, and S. L. Kelly. 1995. Altered P450 activity associated with direct selection for fungal azole resistance. FEBS Lett. 374:174-178.
18. Joseph-Horne, T., D. Hollomon, N. Manning, and S. L. Kelly. 1995. Defective sterol 5,6 desaturase as a cause of azole resistance in Ustilago maydis. FEMS Microbiol. Lett. 127:29-34.
19. Kelly, S. L., and D. E. Kelly. 1993. Molecular studies on azole sensitivity in fungi, p. 199-213. In B. Maresca, G. S. Kobayashi, and H. Yamaguchi (ed.), Molecular biology and its application to medical mycology. Springer-Verlag, Berlin, Germany.
20. Kelly, S. L., D. C. Lamb, D. E. Kelly, J. Loeffler, and H. Einsele. 1996. Resistance to fluconazole in Candida albicans from AIDS patients involving cross-resistance to amphotericin. Lancet 348:1523-1524.
21. Masaphy, S., D. Levanon, Y. Henis, K. Venkateswarlu, and S. L. Kelly. 1996. Evidence for cytochrome P450 and P450-mediated benzo(a)pyrene hydroxylation in the white rot fungus Phanerochaete chrysosporium. FEMS Lett. 135:51-55.
22. Moore, C. B., D. Law, and D. W. Denning. 1993. In vitro activity of D0870 compared with amphotericin B and itraconazole against Aspergillus spp. J. Antimicrob. Chemother. 32:831-836.
23. Omura, T., and R. Sato. 1964. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its haemoprotein nature. J. Biol. Chem. 239:2370-2378.
24. Parkinson, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob. Agents Chemother. 39:1696-1699.
25. Prasad, R., P. de Wergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDRI, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
26. Rinaldi, M. G. 1993. Invasive aspergillosis. Rev. Infect. Dis. 5:1061-1073.
27. Sanglard, D., K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
28. Van Cutsem, J., and P. A. J. Janssen. 1988. In vitro and in vivo models to study the activity of antifungals against Aspergillus, p. 215-227. In H. Vanden Bossche, D. W. R. MacKenzie, and G. Cauwenbergh (ed.), Aspergillus and aspergillosis. Plenum, New York, N.Y.
29. Vanden Bossche, H., P. Marichal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-400.
30. Vanden Bossche, H., P. Marichal, F. C. Odds, L. Le Jeune, and M. C. Coene. 1992. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 36:2602-2610.
31. Venkateswarlu, K., D. W. Denning, N. J. Manning, and S. L. Kelly. 1995. Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. FEMS Microbiol. Lett. 131:337-341.